]>
IRCT20160523028008N31 IRCT 2024-02-21 Hamedan University of Medical Sciences The effects of methylphenidate and atomoxetine on emotional intelligence, executive function and self-efficacy of 12-18-year-old adolescents with ADHD Investigating the effects of methylphenidate and atomoxetine on emotional intelligence, excutive function and self-efficacy of 12-18-year-old adolescents withThe effect of methylphenidate and automoxetine on emotional intelligence, executive function and self-efficacy of adolescents aged 12 to 18 years with Attention Deficit Hyperactivity Disorder (ADHD) 2024-02-28 anticipated 76 Complete https://irct.ir/trial/75574 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The patients will be randomly assigned to intervention and control groups using block randomization. For this purpose, we will prepare four sheets of paper, writing on two sheets the name of the intervention and on the other two sheets the name of the control. The paper sheets will be pooled, placed in a container, and randomly drawn one at a time for each patient without replacement until all four sheets are drawn. The four paper sheets will be then placed back into the container, and this action repeated until the sample size is reached, Blinding description: The person evaluating the outcomes is unaware of patient allocation to intervention or control groups; therefore, the study is conducted as a single-blind trial. 2-3 Attention Deficit Hyperactivity Disorder (ADHD). Intervention 1: Intervention group: The medication Ritalin, manufactured by Kareen (Iran), is initially prescribed at a dose of three-tenths of a milligram per kilogram of body weight per day. Subsequently, the dosage is increased based on individual needs, up to a maximum of 1 milligram per kilogram of body weight. The treatment duration typically spans 12 weeks. Intervention 2: Intervention group: Atomoxetine, manufactured by Tehran Darou Pharmaceutical Company in Iran, is initially administered at a dose of 40 milligrams per day for up to three days, and then gradually increased to 80 milligrams per day.The treatment duration, typically spans 12 weeks. No - There is not a plan to make this available Justification or reason for not sharing IPD is No - There is not a plan to make this available
public Parisa Tavkoli
Farshchian Hospital, Mirzadeh Eshghi Ave.
Hamadan Iran (Islamic Republic of) 6517838695 +98 81 1828 5015 tavkoliparisa08@gmail.com Hamedan University of Medical Sciences scientific Helen Behmanesh
Hamadan
Hamadan Iran (Islamic Republic of) 6517838695 +98 939 448 4107 Behmanesh.Helen@yahoo.com Hamedan University of Medical Sciences Iran (Islamic Republic of) Consent to participation in the study by parents Ages 12 to 18 years Suffering from Attention Deficit Hyperactivity Disorder (ADHD) 12 years 18 years Both The existence of a range of psychotic disorders Autism spectrum disorders Severe physical illnesses intellectual disability F90.0 Attention-deficit hyperactivity disorder, predominantly inattentive type Treatment - Drugs Treatment - Drugs Intervention group: The medication Ritalin, manufactured by Kareen (Iran), is initially prescribed at a dose of three-tenths of a milligram per kilogram of body weight per day. Subsequently, the dosage is increased based on individual needs, up to a maximum of 1 milligram per kilogram of body weight. The treatment duration typically spans 12 weeks Intervention group: Atomoxetine, manufactured by Tehran Darou Pharmaceutical Company in Iran, is initially administered at a dose of 40 milligrams per day for up to three days, and then gradually increased to 80 milligrams per day.The treatment duration, typically spans 12 weeks. Emotional Intelligence. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: Schutt Revised Emotional Intelligence Questionnaire (MSIS). Executive Function. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: Behavior Rating Inventory of Executive Function - Second Edition (BRIEF-2). Self-Efficacy. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: The Self-Efficacy Questionnaire for Children and Adolescents (SEQ-C). Hamedan University of Medical Sciences Approved 2023-12-29 Research Ethic Committee of Hamadan University of Medical Science Vice-chancellor of Research the Technology, Hamadan University of Medical Sciences, Shahid Fahmideh Hamadan Hamadan Iran (Islamic Republic of)